The new guidelines are designed to establish standard molecular marker testing and targeted therapies for patients with primary or metastatic colorectal carcinoma.
The guidelines are open to public comment through April 22.
Click here to read the full set of guidelines.
More articles on gastroenterology:
Dr. Christopher Meyer named CEO of Holzer Health System
Squaring off in GI: Employment vs. private practice
5 most read GI articles – March 30 to April 3
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.